Placental transfer and decay of maternally acquired antimeasles antibodies in Nigerian children

Pediatric Infectious Disease Journal

Volumn 19, Issue 7, 2000, Pages 635-641

  Hartter, Heike K ^a,b   Oyedele, Oluseyi I ^c   Dietz, Klaus ^b   Kreis, Stephanie ^a   Hoffman, Jean P ^a   Muller, Claude P ^a,b  

^a LABORATOIRE NATIONAL DE SANTÉ   (Luxembourg)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Antibody decay; Immunoglobulin G; Measles virus; Placental transfer

Indexed keywords

IMMUNOGLOBULIN G; MATERNAL ANTIBODY; MEASLES ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEVELOPING COUNTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GERMANY; HALF LIFE TIME; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEASLES; MEASLES VACCINATION; NEWBORN; NIGERIA; PASSIVE IMMUNIZATION; PLACENTAL TRANSFER; PRIORITY JOURNAL;

ADULT; ANTIBODIES, VIRAL; COHORT STUDIES; DEVELOPING COUNTRIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MEASLES; MORBILLIVIRUS; NEUTRALIZATION TESTS; NIGERIA; REGRESSION ANALYSIS;

EID: 0033928045     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200007000-00010     Document Type: Article

References (34)

1. Centers for Disease Control. Progress toward global measles control and regional elimination, 1990-1997. MMWR 1998; 47:1049-54.
2. Aaby P, Bukh J, Kronborg D, Lisse IM, da Silva MC. Delayed excess mortality after exposure to measles during the first six months of life. Am J Epidemiol 1990;132:211-19.
3. George K, Joseph A, Muliyil J, Abraham S, Bhattacharji S, John KR. Measles vaccination before nine months. Trop Med Int Health 1998;3:751-6.
4. Black FL. Measles active and passive immunity in a worldwide perspective. Prog Med Virol 1989;36:1-33.
5. De Francisco A, Hall AJ, Unicomb L, Chakraborty J, Yunus M, Sack RB. Maternal measles antibody decay in rural Bangladeshi infants: implications for vaccination schedules. Vaccine 1998;16:564-8.
6. Kiepiela P, Coovadia HM, Loening WE, Coward P, Abdool Karim SS. Loss of maternal measles antibody in black South African infants in the first year of life: implications for age of vaccination. S Afr Med J 1991;79:145-8.
7. Fagbule D, Orifunmishe F. Measles and childhood mortality in semi-urban Nigeria. Afr J Med Med Sci 1988;17:181-5.
8. Chen RT, Markowitz LE, Albrecht P, et al. Measles antibody: reevaluation of protective titers. J Infect Dis 1990;162:1036-42.
9. Ratnam S, Gadag V, West R et al. Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody. J Clin Microbiol 1995;33:811-5.
10. Bouche F, Ammerlaan W, Berthet F, Houard S, Schneider F, Muller CP. Immunosorbent assay based on recombinant hemagglutinin protein produced in a high-efficiency mammalian expression system for surveillance of measles immunity. J Clin Microbiol 1998;36:721-6.
11. Forsey T, Heath AB, Minor PD. The First International Standard for anti-measles serum. Biologicals 1991;19:237-41.
12. Huiss S, Damien B, Schneider F, Muller CP. Characteristics of asymptomatic secondary immune responses to measles virus in late convalescent donors. Clin Exp Immunol 1997; 109:416-20.
13. Janes MD, Macfarlane SB, Moody JB. Height and weight growth standards for Nigerian children. Ann Trop Paediatr 1981;1:27-37.
14. Mood AM. Introduction to the theory of statistics. New York: McGraw-Hill, 1950.
15. Hartter HK, de Swart RL, Hanses F, et al. Evaluation of different measles IgG assays based on recombinant proteins using a panel of low-titre sera. J Virol Methods 2000;84:191-200.
16. Taylor WR, Kalisa R, Ma-Disu M, Weinman JM. Measles control efforts in urban Africa complicated by high incidence of measles in the first year of life. Am J Epidemiol 1988;127: 788-94.
17. Ibia EO, Asindi AA. Measles in Nigerian children in Calabar during the era of expanded programme on immunization. Trop Geogr Med 1990;42:226-32.
18. Dabis F, Waldman RJ, Mann GF, Commenges D, Madzou G, Jones TS. Loss of maternal measles antibody during infancy in an African city. Int J Epidemiol 1989;18:264-8.
19. Ministry of Health of Kenya and World Health Organization. Measles immunity in the first year after birth and the optimum age for vaccination in Kenyan children. Bull WHO 1977;55:21-31.
20. Gendrel D, Engohan E, Gendrel C. Disparition des anticorps antirougeoleux d'origin maternelle chez le nourisson gabonais. OCEAC Bull 1986;76:67-71.
21. Babaniyi OA, Parakoyi DB, Aiyedun BA, Bello MA. Loss of maternally-acquired measles antibody during infancy in Ilorin, Nigeria. J Trop Pediatr 1995;41:115-7.
22. Lennon JL, Black FL. Maternally derived measles immunity in the era of vaccine-protected mothers. J Pediatr 1986;108: 671-6.
23. Cutts F. Measles vaccination in early infancy and persistence of antibody. Lancet 1990;335:913.
24. Brambell FW. The transmission of immunity from mother to young and the catabolism of immunoglobulins. Lancet 1966; 2:1087-93.
25. Landor M. Maternal-fetal transfer of immunoglobulins. Ann Allergy Asthma Immunol 1995;74:279-83.
26. Griffiths PD, Berney SI, Argent S, Heath RB. Antibody against viruses in maternal and cord sera: specific antibody is concentrated on the fetal side of the circulation. J Hyg 1982;89:303-10.
27. Goncalves G, Cutts FT, Hills M, Rebelo-Andrade H, Trigo FA, Barros H. Transplacental transfer of measles and total IgG. Epidemiol Infect 1999;122:273-9.
28. Hood N, Chan MC, Maxwell SM, Familusi JB, Hart CA. Placental transfer of tetanus toxoid antibodies in Nigerian mothers. Ann Trop Paediatr 1994;14:179-82.
29. Markowitz LE, Albrecht P, Rhodes P et al. Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Kaiser Permanent Measles Vaccine Trial Team. Pediatrics 1996;97:53-8.
30. Pabst HF, Boothe PM, Carson MM. A comparison of alternate immunization regimes for measles in vaccinated populations. Vaccine 1999;17:182-92.
31. De Serres G, Joly JR, Fauvel M, Meyer F, Masse B, Boulianne N. Passive immunity against measles during the first 8 months of life of infants born to vaccinated mothers or to mothers who sustained measles. Vaccine 1997;15:620-3.
32. Gans HA, Arvin AM, Galinus J, Logan L, DeHovitz R, Maldonado Y. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. JAMA 1998;280:527-32.
33. Kumar ML, Johnson CE, Chui LW, Whitwell JK, Staehle B, Nalin D. Immune response to measles vaccine in 6-month-old infants of measles seronegative mothers. Vaccine 1998;16: 2047-51.
34. Garly ML, Martins CL, Bale C et al. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy. Int J Epidemiol 1999;28:347-52.